Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity

A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES

Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189

Positional cloning of the mouse obese gene and its human homologue

Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419

Real time quantitative PCR.Preprint

Heid, C., Stevens, J., Livak, K. J., & Williams, P. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,180

Weight-Reducing Effects of the Plasma Protein Encoded by the obese Gene

Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451

Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice

Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017

Obesity and insulin resistance

Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345

The Spread of the Obesity Epidemic in the United States, 1991-1998

Mokdad, A. H. (1999) · JAMA · doi:10.1001/jama.282.16.1519 · Cited by 2,384

Cellular energy utilization and molecular origin of standard metabolic rate in mammals

Rolfe, D. F., & Brown, G. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.731 · Cited by 2,021

Annual Deaths Attributable to Obesity in the United States

Allison, D. B. (1999) · JAMA · doi:10.1001/jama.282.16.1530 · Cited by 1,863

Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action

Frederich, R. C., Hamann, A., Anderson, S., Löllmann, B., Lowell, B. B., & Flier, J. S. (1995) · Nature Medicine · doi:10.1038/nm1295-1311 · Cited by 1,660

Endogenous ways to stimulate brown adipose tissue in humans

Broeders, E. P. M., Bouvy, N. D., & Lichtenbelt, W. D. V. M. (2014) · Annals of Medicine · doi:10.3109/07853890.2013.874663 · Cited by 37

Modulation of energy balance by fibroblast growth factor 21

Ramos, D. C., & Aguilar-Salinas, C. A. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0023 · Cited by 36

Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia

Saint-Laurent, C., García, S., Sarrazy, V., Dumas, K., Authier, F., Sore, S., Tran, A., Gual, P., Gennero, I., Salles, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195876 · Cited by 34

Controversies in the Mechanism of Total Parenteral Nutrition Induced Pathology

Kumar, J., & Teckman, J. H. (2015) · Children · doi:10.3390/children2030358 · Cited by 33

Klotho Protein and Cardio-Vascular System

Tyurenkov, I. N., Perfilova, V. N., Нестерова, А. А., & Glinka, Y. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921020024 · Cited by 34

Plasma Concentrations of Fibroblast Growth Factors 21 and 19 in Patients with Cushing's Syndrome

Ďurovcová, V., Marek, J., Hána, V., Matoulek, M., Zikán, V., Haluzíková, D., Kaválková, P., Lacinová, Z., Kršek, M., & Haluzı́k, M. (2010) · Physiological Research · doi:10.33549/physiolres.931801 · Cited by 33

Fibroblast growth factor (Fgf) signaling pathway regulates liver homeostasis in zebrafish

Tsai, S.-M., Liu, D., & Wang, W.-P. (2012) · Transgenic Research · doi:10.1007/s11248-012-9636-9 · Cited by 32

Impact of gut hormone FGF-19 on type-2 diabetes and mitochondrial recovery in a prospective study of obese diabetic women undergoing bariatric surgery

de la Escalera, L. M., Kyrou, I., Vrbíková, J., Hainer, V., Šrámková, P., Fried, M., Piya, M. K., Kumar, S., Tripathi, G., & McTernan, P. G. (2017) · BMC Medicine · doi:10.1186/s12916-017-0797-5 · Cited by 32

Cholestyramine treatment of healthy humans rapidly induces transient hypertriglyceridemia when treatment is initiated

Sjöberg, B. G., Straniero, S., Angelin, B., & Rudling, M. J. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00416.2016 · Cited by 32

A systematic dissection of sequence elements determining β-Klotho and FGF interaction and signaling

Shi, S. Y., Lu, Y., Richardson, J., Min, X., Weiszmann, J., Richards, W. G., Wang, Z., Zhang, Z., Zhang, J., & Li, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-29396-5 · Cited by 31

Non-Alcoholic Steatohepatitis: From Pathophysiology to Novel Therapies

Jahn, D., Rau, M., Wohlfahrt, J., Hermanns, H. M., & Geier, A. (2016) · Digestive Diseases · doi:10.1159/000444547 · Cited by 32

Pregnane X receptor (PXR) deficiency improves high fat diet-induced obesity via induction of fibroblast growth factor 15 (FGF15) expression

Zhao, L., Xu, J., Shi, Z., Englert, N. A., & Zhang, S. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.07.019 · Cited by 32

FGF21 as a Therapeutic Reagent

Zhao, Y., Dunbar, J. D., & Kharitonenkov, A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_14 · Cited by 30

Grinding levels of raspberry pomace affect intestinal microbial activity, lipid and glucose metabolism in Wistar rats

Fotschki, B., Juśkiewicz, J., Jurgoński, A., Kosmala, M., Milala, J., Zduńczyk, Z., & Markowski, J. (2019) · Food Research International · doi:10.1016/j.foodres.2019.03.014 · Cited by 31

Metabolic effects of basic fibroblast growth factor in streptozotocin-induced diabetic rats: A 1H NMR-based metabolomics investigation

Lin, X., Zhao, L., Tang, S., Zhou, Q., Lin, Q., Li, X., Zheng, H. X., & Gao, H. (2016) · Scientific Reports · doi:10.1038/srep36474 · Cited by 30

Early Effects of Sleeve Gastrectomy on Obesity-Related Cytokines and Bile Acid Metabolism in Morbidly Obese Japanese Patients

Shimizu, H., Hatao, F., Imamura, K., Takanishi, K., & Tsujino, M. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2756-9 · Cited by 31

Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease

van Zutphen, T., Bertolini, A., de Vries, H. D., Bloks, V. W., de Boer, J. F., Jonker, J. W., & Kuipers, F. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_233 · Cited by 31

FGF19 (fibroblast growth factor 19) as a novel target gene for activating transcription factor 4 in response to endoplasmic reticulum stress

Shimizu, M., Li, J., Maruyama, R., Inoue, J., & Sato, R. (2012) · Biochemical Journal · doi:10.1042/bj20121393 · Cited by 29

Bile Acids in the Treatment of Cardiometabolic Diseases

Vı́tek, L. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5496 · Cited by 29

Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together

Maresca, R., Mignini, I., Varca, S., Calvez, V., Termite, F., Esposto, G., Laterza, L., Scaldaferri, F., Ainora, M. E., Gasbarrini, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063278 · Cited by 29

Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance

Bozadjieva-Kramer, N., Shin, J. H., Li, Z., Rupp, A. C., Miller, N., Kernodle, S., Lanthier, N., Henry, P., Seshadri, N., Myronovych, A., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.174164 · Cited by 28

Novel Targeted Therapy Strategies for Biliary Tract Cancers and Hepatocellular Carcinoma

DeLeon, T., Ahn, D. H., Bogenberger, J. M., Anastasiadis, P. Z., Arora, M., Ramanathan, R. K., Aqel, B. A., Vasmatzis, G., Truty, M. J., Öklü, R., et al. (2018) · Future Oncology · doi:10.2217/fon-2017-0451 · Cited by 28

Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese Mice

Yu, X. X., Watts, L. M., Manchem, V. P., Chakravarty, K., Monia, B. P., McCaleb, M. L., & Bhanot, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066923 · Cited by 28

Gut as an emerging organ for the treatment of diabetes: focus on mechanism of action of bariatric and endoscopic interventions

Haluzı́k, M., Kratochvílová, H., Haluzíková, D., & Mráz, M. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0438 · Cited by 30

Comprehensive Analysis of the Characteristics and Differences in Adult and Newborn Brown Adipose Tissue (BAT): Newborn BAT Is a More Active/Dynamic BAT

Liu, J., Zhang, C., Zhang, B., Sheng, Y., Xu, W., Luo, Y., He, X., & Huang, K. (2020) · Cells · doi:10.3390/cells9010201 · Cited by 28

SHIP2, a factor associated with diet-induced obesity and insulin sensitivity, attenuates FGF signaling in vivo

Jurynec, M. J., & Grunwald, D. J. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.000703 · Cited by 26

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD

Dibba, P., Li, A. A., Perumpail, B. J., John, N., Sallam, S., Shah, N. D., Kwong, W., Cholankeril, G. T., Kim, D., & Ahmed, A. (2018) · Diseases · doi:10.3390/diseases6030083 · Cited by 27

Cholecystectomy Causes Ultrasound Evidence of Increased Hepatic Steatosis

Yun, S., Choi, D., Lee, K. G., Kim, H., Kang, B., Kim, H., & Paik, S. S. (2016) · World Journal of Surgery · doi:10.1007/s00268-015-3396-7 · Cited by 28

The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target

Liu, W., Huang, S., Shi, K., Zhao, C., Chen, L.-L., Braddock, M., Chen, Y., Feng, W., & Zheng, M. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.944898 · Cited by 26

Novel Strategies to Prevent Total Parenteral Nutrition‐Induced Gut and Liver Inflammation, and Adverse Metabolic Outcomes

Lucchinetti, E., Lou, P., Wawrzyniak, P., Wawrzyniak, M., Scharl, M. M., Holtzhauer, G., Krämer, S. D., Hersberger, M., Rogler, G., & Zaugg, M. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901270 · Cited by 29

Association of FGF‐19 and FGF‐21 levels with primary sarcopenia

Soytaş, R. B., Suzan, V., Arman, P., Gedik, T. E., Unal, D., Cengiz, M., Bolayırlı, I., Erdinçler, D. S., Doventas, A., & Yavuzer, H. (2021) · Geriatrics & Gerontology International · doi:10.1111/ggi.14263 · Cited by 23

Enhanced GIP Secretion in Obesity Is Associated with Biochemical Alteration and miRNA Contribution to the Development of Liver Steatosis

Góralska, J., Raźny, U., Polus, A., Dziewońska, A., Gruca, A., Zdzienicka, A., Dembinska-Kiec, A., Solnica, B., Micek, A., Kapusta, M., et al. (2020) · Nutrients · doi:10.3390/nu12020476 · Cited by 26

Sulfated Glycosaminoglycans Are Required for Specific and Sensitive Fibroblast Growth Factor (FGF) 19 Signaling via FGF Receptor 4 and betaKlotho

Nakamura, M., Uehara, Y., Asada, M., Honda, E., Nagai, N., Kimata, K., Suzuki, M., & Imamura, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.251140 · Cited by 25

Involvement of heparan sulfate 6-O-sulfation in the regulation of energy metabolism and the alteration of thyroid hormone levels in male mice

Nagai, N., Habuchi, H., Sugaya, N., Nakamura, M., Imamura, T., Watanabe, H., & Kimata, K. (2013) · Glycobiology · doi:10.1093/glycob/cwt037 · Cited by 25

FGF9 inhibits browning program of white adipocytes and associates with human obesity

Sun, Y., Wang, R., Zhao, S., Li, W., Liu, W., Tang, L., Wang, Z., Wang, W., Liu, R., Ning, G., et al. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0151 · Cited by 25

Endocrine Fibroblast Growth Factors in Relation to Stress Signaling

Shimizu, M., & Sato, R. (2022) · Cells · doi:10.3390/cells11030505 · Cited by 25

Mechanistic target of rapamycin complex 1 is an essential mediator of metabolic and mitogenic effects of fibroblast growth factor 19 in hepatoma cells

Wan, Z. Y., Tian, J. S., Tan, H. W. S., Chow, A. L., Sim, A. Y. L., Ban, K. H.-K., & Long, Y. C. (2016) · Hepatology · doi:10.1002/hep.28639 · Cited by 25

Therapeutic utilities of fibroblast growth factor 19

Wu, X., & Li, Y. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.624514 · Cited by 23

Bariatric Surgery: Prevalence, Predictors, and Mechanisms of Diabetes Remission

Argyropoulos, G. A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0590-9 · Cited by 23

Fibroblast growth factor 19-targeted therapies for the treatment of metabolic disease

Rysz, J., Gluba-Brzózka, A., Mikhailidis, D. P., & Banach, M. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1006357 · Cited by 23

Ablation of liver Fxr results in an increased colonic mucus barrier in mice

Ijssennagger, N., van Rooijen, K. S., Magnúsdóttir, S., Pittol, J. M. R., Willemsen, E. C. L., de Zoete, M. R., Baars, M. J. D., Stege, P. B., Colliva, C., Pellicciari, R., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100344 · Cited by 23

N‐acetyl‐seryl‐aspartyl‐lysyl‐proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects

Kanasaki, K. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13219 · Cited by 23

Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients

Yamamoto, S., Koyama, D., Igarashi, R., Maki, T., Mizuno, H., Furukawa, Y., & Kuro‐o, M. (2020) · Internal Medicine · doi:10.2169/internalmedicine.3597-19 · Cited by 23

Modulation of Metabolic Syndrome by Fibroblast Growth Factor 19 (FGF19)?

Strack, A. M., & Myers, R. W. (2004) · Endocrinology · doi:10.1210/en.2004-0367 · Cited by 23

Fighting obesity by targeting factors regulating beige adipocytes

McQueen, A. E., Koliwad, S. K., & Wang, J.-C. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000509 · Cited by 24

FGF19 Exhibits Neuroprotective Effects on Adult Mammalian Photoreceptors In Vitro

Siffroi‐Fernandez, S., Felder‐Schmittbuhl, M., Khanna, H., Swaroop, A., & Hicks, D. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1272 · Cited by 22

Reduced Levels of Serum FGF19 and Impaired Expression of Receptors for Endocrine FGFs in Adipose Tissue From HIV-Infected Patients

Gallego-Escuredo, J. M., Domingo, P., Gutiérrez, M. D. M., Mateo, G. M., Cabeza, M. C., Fontanet, À., Vidal, F., Domingo, J. C., Giralt, M., & Villarroya, F. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318271c2c7 · Cited by 22

Decreased placental and muscular expression of the fibroblast growth factor 19 in gestational diabetes mellitus

Wang, D., Xu, S., Ding, W., Zhu, C., Deng, S., Qiu, X., & Wang, Z. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12859 · Cited by 21

The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism

Cariello, M., Piglionica, M., Gadaleta, R. M., & Moschetta, A. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_235 · Cited by 22

FGF19 alleviates palmitate-induced atrophy in C2C12 cells by inhibiting mitochondrial overload and insulin resistance

Sun, Y., Yang, Z.-X., Ren, F., & Fang, B. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.04.186 · Cited by 22

Surgery-Induced Weight Loss and Changes in Hormonally Active Fibroblast Growth Factors: a Systematic Review and Meta-Analysis

Hosseinzadeh, A., Roever, L., & Alizadeh, S. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04807-7 · Cited by 22

Enhanced In Vitro Refolding of Fibroblast Growth Factor 15 with the Assistance of SUMO Fusion Partner

Kong, B., & Guo, G. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020307 · Cited by 22

The role of FGF19 in metabolic regulation: insights from preclinical models to clinical trials

de Carvalho, M. B., Jorge, G. M. C. P., Zanardo, L. W., Hamada, L. M., Izabel, L. D. S., Santoro, S., & Magdalon, J. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00156.2024 · Cited by 23

FGF19 protects against obesity-induced bone loss by promoting osteogenic differentiation

Guo, A., Li, K., Tian, H., Tao, B., Xiao, Q., & Jiang, D. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112524 · Cited by 21

Exploring the Structural and Functional Diversity among FGF Signals: A Comparative Study of Human, Mouse, and Xenopus FGF Ligands in Embryonic Development and Cancer Pathogenesis

Goutam, R. S., Kumar, V., Lee, U., & Kim, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087556 · Cited by 20

Selective Regulation of FGF19 and FGF21 Expression by Cellular and Nutritional Stress

SHIMIZU, M., MORIMOTO, H., Maruyama, R., Inoue, J., & Sato, R. (2015) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.61.154 · Cited by 21

Crosstalk between Fibroblast Growth Factor (FGF) Receptor and Integrin through Direct Integrin Binding to FGF and Resulting Integrin-FGF-FGFR Ternary Complex Formation

Mori, S., & Takada, Y. (2013) · Medical Sciences · doi:10.3390/medsci1010020 · Cited by 20

Variant Near FGF5 Has Stronger Effects on Blood Pressure in Chinese With a Higher Body Mass Index

Li, J., Shi, J., Huang, W., Sun, J., Wu, Y., Duan, Q., Luo, J., Lange, L. A., Gordon‐Larsen, P., Zheng, S. L., et al. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpu263 · Cited by 21

Understanding the Structure-Function Relationship between FGF19 and Its Mitogenic and Metabolic Activities

Wu, X., & Li, Y. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_13 · Cited by 21

Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals

Renner, O., Harsch, S., Matysik, S., Lütjohann, D., Schmitz, G., & Stange, E. F. (2014) · United European Gastroenterology Journal · doi:10.1177/2050640614527938 · Cited by 21

Physiological Appetite Regulation and Bariatric Surgery

Ramasamy, I. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051347 · Cited by 21

Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients

Tang, M., Su, J., Xu, T., Wang, X., Zhang, D.-M., & Wang, X.-H. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0475-1 · Cited by 20

Fibroblast Growth Factor 19 and Fibroblast Growth Factor 21 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Gastric Bypass

Guo, J., Chen, H.-H., Lee, W., Chen, S., Lee, S., & Chen, C. (2022) · Nutrients · doi:10.3390/nu14030645 · Cited by 21

Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention

Shao, Y., Chen, S., Liu, H., & Liu, J. (2023) · Nutrition & Metabolism · doi:10.1186/s12986-023-00748-x · Cited by 20

Use of Farnesoid X Receptor Agonists to Treat Nonalcoholic Fatty Liver Disease

Sanyal, A. J. (2015) · Digestive Diseases · doi:10.1159/000371698 · Cited by 20

Detection of thermogenesis in rodents in response to anti-obesity drugs and genetic modification

Arch, J. R. S., & Trayhurn, P. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00064 · Cited by 20

Hormonal and nutritional signalling in the control of brown and beige adipose tissue activation and recruitment

Giralt, M., Cairó, M., & Villarroya, F. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.08.005 · Cited by 19

Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes

Donate-Correa, J., Martín-Núñez, E., González-Luis, A., Ferri, C., Luis-Rodríguez, D., TAGUA, V. G., Mora-Fernández, C., & Navarro-González, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122583 · Cited by 17

Ampelopsis grossedentata improves type 2 diabetes mellitus through modulating the gut microbiota and bile acid metabolism

Hu, Y., Li, M., Ding, L., Peng, C., Wu, Y., Liu, W., Zhao, D., Qin, L., Guo, X., Wu, L., et al. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105622 · Cited by 18

Fibroblast growth factors 19 and 21 in acute liver damage

Shan, Z., Álvarez‐Sola, G., Uriarte, I., Arechederra, M., Fernández‐Barrena, M. G., Berasain, C., Ju, C., & Avila, M. A. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.05.26 · Cited by 19

The Pathophysiology of Portal Hypertension

Ramkissoon, R. A., Cao, S., & Shah, V. H. (2024) · Clinics in Liver Disease · doi:10.1016/j.cld.2024.03.001 · Cited by 19

Liver–gut axis signaling regulates circadian energy metabolism in shift workers

Yang, Z., Zarbl, H., Kong, B., Taylor, R. E., Black, K., Kipen, H. M., Basaly, V., Fang, M., & Guo, G. L. (2024) · The FASEB Journal · doi:10.1096/fj.202402102r · Cited by 17

Genome-Wide Copy Number Variations Inferred from SNP Genotyping Arrays Using a Large White and Minzhu Intercross Population

Wang, L., Xin, L. I. U., Zhang, L., Yan, H., Luo, W., Liang, J., Cheng, D., Chen, S., 马小军, Song, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074879 · Cited by 17

The thermogenic circuit: Regulators of thermogenic competency and differentiation

Lynes, M. D., & Tseng, Y. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2015.03.001 · Cited by 18

Fibroblast growth factor 19 improves cardiac function and mitochondrial energy homoeostasis in the diabetic heart

Xu, W., Wang, Y., Guo, Y., Liu, J., Ma, L., Cao, W., Yu, B., & Zhou, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.046 · Cited by 17

Roles of Gut-Derived Secretory Factors in the Pathogenesis of Non-Alcoholic Fatty Liver Disease and Their Possible Clinical Applications

Okubo, H., Kushiyama, A., Nakatsu, Y., Yamamotoya, T., Matsunaga, Y., Fujishiro, M., Sakoda, H., Ohno, H., Yoneda, M., & Asano, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103064 · Cited by 18

A Unique FGF23 with the Ability to Activate FGFR Signaling through Both αKlotho and βKlotho

Wu, X., Weiszmann, J., Ge, H., Baribault, H., Stevens, J. L., Hawkins, N., Vonderfecht, S. L., Gardner, J., Gupte, J., Sheng, J., et al. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.02.027 · Cited by 17

Association of serum fibroblast growth factor 19 levels with visceral fat accumulation is independent of glucose tolerance status

Hu, X., Xiong, Q., Xu, Y., Zhang, X., Pan, X., Ma, X., Bao, Y., & Jia, W. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.10.009 · Cited by 17

Fibroblast Growth Factor 21 Is Associated With Bone Mineral Density, but not With Bone Turnover Markers and Fractures in Chinese Postmenopausal Women

Hu, W., He, J., Fu, W., Wang, C., Yue, H., Gu, J., Zhang, H., & Zhang, Z. (2018) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2018.08.005 · Cited by 17

Chenodeoxycholic acid suppresses the activation of acetyl-coenzyme A carboxylase-α gene transcription by the liver X receptor agonist T0-901317

Talukdar, S., Bhatnagar, S., Dridi, S., & Hillgartner, F. B. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700189-jlr200 · Cited by 16

Ostα−/−mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity

Wheeler, S. G., Hammond, C. L., Jornayvaz, F. R., Samuel, V. T., Shulman, G. I., Soroka, C. J., Boyer, J. L., Hinkle, P. M., & Ballatori, N. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00368.2013 · Cited by 16

Serum fibroblast growth factor 19 is decreased in patients with overt hypothyroidism and subclinical hypothyroidism

Lai, Y., Wang, H., Xia, X., Wang, Z., Fan, C., Wang, H., Zhang, H., Ding, S., Teng, W., & Shan, Z. (2016) · Medicine · doi:10.1097/md.0000000000005001 · Cited by 16

Bile acid receptors link nutrient sensing to metabolic regulation

Li, J., & Li, T. (2017) · Liver Research · doi:10.1016/j.livres.2017.04.001 · Cited by 16

Proceedings of the 2017 ASPEN Research Workshop—Gastric Bypass: Role of the Gut

Jain, A. K., le Roux, C. W., Puri, P., Tavakkoli, A., Gletsu-Miller, N. A., Laferrère, B., Kellermayer, R., DiBaise, J. K., Martindale, R. G., & Wolfe, B. M. (2018) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1121 · Cited by 17

Decrease of FGF19 contributes to the increase of fasting glucose in human in an insulin-independent manner

Zhang, J.-L., Li, H., Bai, N., Xu, Y., Song, Q., Zhang, L., Wu, G., Chen, S., Hou, X., Wang, C., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01018-5 · Cited by 16

Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics

Pandey, H., Goel, P., Srinivasan, V. M., Tang, D. W. T., Wong, S. H., & Lal, D. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i6.106849 · Cited by 20

Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetes

Liu, W., Tang, M., Xu, T., Su, J., Wang, X., Xu, F., Zhang, D., Zhu, Q. X., Cao, J. J., & Wang, H. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00552-0 · Cited by 15

Fibroblast growth factor receptor 4 as a prognostic indicator in triple-negative breast cancer

Wei, W., Cao, S., Liu, J., Wang, Y., Song, Q., Leha, A., Sun, S., Zhang, X., Liang, X., & Jiang, Y. (2020) · Translational Cancer Research · doi:10.21037/tcr-20-1756 · Cited by 15

Evaluation of the effect of oral taurine supplementation on fasting levels of fibroblast growth factors, β-Klotho co-receptor, some biochemical indices and body composition in obese women on a weight-loss diet: a study protocol for a double-blind, randomized controlled trial

Haidari, F., Asadi, M., Asl, J. M., & Angali, K. A. (2019) · Trials · doi:10.1186/s13063-019-3421-5 · Cited by 15

FGF15/FGF19 alleviates insulin resistance and upregulates placental IRS1/GLUT expression in pregnant mice fed a high-fat diet

Zhao, S., Wang, D., Li, Z., Xu, S., Chen, H., Ding, W., Yang, J., Zhao, W., Sun, B., & Wang, Z. (2021) · Placenta · doi:10.1016/j.placenta.2021.07.286 · Cited by 16

Bile Acid Metabolism

Chiang, J. Y. L. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_12 · Cited by 15

Endocrine Function after Bariatric Surgery

Kim, K., & Sandoval, D. A. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160019 · Cited by 17

Exploring endocrine FGFs - structures, functions and biomedical applications

Phan, P. (2024) · International Journal of Biochemistry and Molecular Biology · doi:10.62347/palk2137 · Cited by 16

Intestinal farnesoid X receptor signaling controls hepatic fatty acid oxidation

Lu, D., Liu, Y., Luo, Y., Zhao, J., Feng, C., Xue, L., Xu, J., Wang, Q., Yan, T., Xiao, P., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159089 · Cited by 14

Impact of cholecystectomy on the gut-liver axis and metabolic disorders

Raposo, M. A., Oliveira, E., Santos, A., Guadagnini, D., Mourabit, H. E., Housset, C., Lemoinne, S., & Saad, M. J. A. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102370 · Cited by 17

Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)

López-Pascual, A., Russo-Cabrera, J. S., Ardaiz, N., Palmer, T., Graham, A.-R., Uriarte, I., Gomar, C., Ruiz-Guillamon, D., Latasa, M. U., Arechederra, M., et al. (2024) · Clinical Science · doi:10.1042/cs20241137 · Cited by 14

βklotho is essential for the anti‐endothelial mesenchymal transition effects of N‐acetyl‐seryl‐aspartyl‐lysyl‐proline

Gao, R., Kanasaki, K., Li, J., Kitada, M., Okazaki, T., & Koya, D. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12638 · Cited by 14

Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone Formation

Lin, J., Lü, M., Shao, W., Chen, Z., Zhu, W., Lu, L., Jia, H., Cai, D., Qin, L., & Chen, J. (2016) · Scientific Reports · doi:10.1038/srep30215 · Cited by 14

Fibroblast Growth Factor 19 Alters Bile Acids to Induce Dysbiosis in Mice With Alcohol-Induced Liver Disease

Ferrell, J. M., Dilts, M., Pokhrel, S., Stahl, Z., Boehme, S., Wang, X., & Chiang, J. Y. L. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.02.015 · Cited by 15

Printed in U.S.A. Copyright © 2002 by The Endocrine Society Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity

Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D. M., et al. (2013)

Fibroblast Growth Factor 19 Increases Metabolic Rate and Reverses Dietary and Leptin-Deficient Diabetes

Fu, L., John, L. M., Adams, S. H., Yu, X. X., Tomlinson, E., Renz, M. E., Williams, P. M., Soriano, R. H., Corpuz, R. T., Moffat, B., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1671 · Cited by 584

Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/en.2003-1671 Fibroblast Growth Factor 19 Increases Metabolic Rate and Reverses Dietary and Leptin-Deficient Diabetes

Fu, L., John, L. M., Adams, S. H., Yu, X. X., Tomlinson, E., Renz, M. E., Williams, P. M., Soriano, R., Corpuz, R. T., Moffat, B., et al. (2013)

Cell-autonomous Action of the FGF19 Promotes UCP1 Expression and Function in Human Brown Adipocytes

Zangerolamo, L., Huang, T. L., Barbosa, H. C. L., & Tseng, Y. (2024) · Physiology · doi:10.1152/physiol.2024.39.s1.1769

The anti‐obesity effect of FGF19 occurs independent of the thermogenic protein UCP1

Samms, R. J., Antonellis, P. J., Bauer, S. M., Smith, D. P., O’Farrell, L. S., Culver, A. E., Hamang, M., Perfield, J. W., Coşkun, T., Yaden, B. C., et al. (2017) · The FASEB Journal · doi:10.1096/fasebj.31.1_supplement.886.12